Skip to main content

Cancer Causes & Control

Ausgabe 2/2013

Special section on “H pylori/gastric cancer in Latin America”

Inhalt (22 Artikel)

Open Access Commentary

Latin America: ripe for cutting-edge research proposals for prevention and control of Helicobacter pylori

Eduardo Lazcano-Ponce, María Elena Martínez

Original paper

Epidemiology of Helicobacter pylori infection in six Latin American countries (SWOG Trial S0701)

Carolina Porras, Jesse Nodora, Rachael Sexton, Catterina Ferreccio, Silvia Jimenez, Ricardo L. Dominguez, Paz Cook, Garnet Anderson, Douglas R. Morgan, Laurence H. Baker, E. Robert Greenberg, Rolando Herrero

Original paper

Risk factors for gastric cancer in Latin America: a meta-analysis

Patricia Bonequi, Fernando Meneses-González, Pelayo Correa, Charles S. Rabkin, M. Constanza Camargo

Original paper

Gastric cancer incidence estimation in a resource-limited nation: use of endoscopy registry methodology

Ricardo L. Dominguez, Seth D. Crockett, Jennifer L. Lund, Lia P. Suazo, Paris Heidt, Christopher Martin, Douglas R. Morgan

Original paper

The utility of serologic tests as biomarkers for Helicobacter pylori-associated precancerous lesions and gastric cancer varies between Latin American countries

L. Flores-Luna, M. Camorlinga-Ponce, G. Hernandez-Suarez, E. Kasamatsu, M. E. Martínez, R. Murillo, E. Lazcano, J. Torres

Original paper

Gastric cancer incidence and mortality is associated with altitude in the mountainous regions of Pacific Latin America

Javier Torres, Pelayo Correa, Catterina Ferreccio, Gustavo Hernandez-Suarez, Rolando Herrero, Maria Cavazza-Porro, Ricardo Dominguez, Douglas Morgan

Review article

A meta-analysis of coffee and tea consumption and the risk of glioma in adults

Stefano Malerba, Carlotta Galeone, Claudio Pelucchi, Federica Turati, Mia Hashibe, Carlo La Vecchia, Alessandra Tavani

Original Paper

Racial disparities in colorectal cancer incidence by type 2 diabetes mellitus status

Philip P. Cavicchia, Swann Arp Adams, Susan E. Steck, James R. Hussey, Jihong Liu, Virginie G. Daguisé, James R. Hebert

Original paper

Body size and risk of Hodgkin’s lymphoma by age and gender: a population-based case–control study in Connecticut and Massachusetts

Qian Li, Ellen T. Chang, Bryan A. Bassig, Min Dai, Qin Qin, Yongshun Gao, Yawei Zhang, Tongzhang Zheng

Original paper

A prospective study of socioeconomic status, prostate cancer screening and incidence among men at high risk for prostate cancer

Andrew Rundle, Kathryn M. Neckerman, Daniel Sheehan, Michelle Jankowski, Oleksandr N. Kryvenko, Deliang Tang, Benjamin A. Rybicki

Original paper

Body mass index, tumor characteristics, and prognosis following diagnosis of early-stage breast cancer in a mammographically screened population

Aruna Kamineni, Melissa L. Anderson, Emily White, Stephen H. Taplin, Peggy Porter, Rachel Ballard-Barbash, Kathleen Malone, Diana S. M. Buist

Original paper

Contribution of diet and physical activity to metabolic parameters among survivors of childhood leukemia

Emily S. Tonorezos, Kim Robien, Debra Eshelman-Kent, Chaya S. Moskowitz, Timothy S. Church, Robert Ross, Kevin C. Oeffinger

Original paper

Associations of adiponectin and leptin with stage and grade of PSA-detected prostate cancer: the ProtecT study

Anya Burton, Richard M. Martin, Jeff Holly, J. Athene Lane, Jenny L. Donovan, Freddie C. Hamdy, David E. Neal, Kate Tilling

Original paper

Risk factors for young-onset colorectal cancer

Valentina Rosato, Cristina Bosetti, Fabio Levi, Jerry Polesel, Antonella Zucchetto, Eva Negri, Carlo La Vecchia

Original paper

Parental nutrient intake and risk of retinoblastoma resulting from new germline RB1 mutation

Greta R. Bunin, Yimei Li, Arupa Ganguly, Anna T. Meadows, Marilyn Tseng

Original paper

Household endotoxin levels and the risk of non-Hodgkin lymphoma

Jun Wang, Wendy Cozen, Peter S. Thorne, Kiros Berhane, James R. Cerhan, Patricia Hartge, Mary H. Ward, Anneclaire J. De Roos, Richard K. Severson, Lindsay M. Morton, Leslie Bernstein, Martha S. Linet, Joanne S. Colt

Original paper

Use of antihypertensive medications and breast cancer risk

Babette S. Saltzman, Noel S. Weiss, Weiva Sieh, Annette L. Fitzpatrick, Anne McTiernan, Janet R. Daling, Christopher I. Li

Original paper

Nutrients related to one-carbon metabolism and risk of renal cell cancer

Eunyoung Cho, Edward L. Giovannucci, Hee-Kyung Joh

Original paper

Risk of localized and advanced prostate cancer among immigrants versus native-born Swedish men: a nation-wide population-based study

Stacy Loeb, Linda Drevin, David Robinson, Erik Holmberg, Sigrid Carlsson, Mats Lambe, Pär Stattin

Original Paper

Parental alcohol consumption and risk of childhood acute lymphoblastic leukemia and brain tumors

Elizabeth Milne, Kathryn R. Greenop, Rodney J. Scott, Nicholas H. de Klerk, Carol Bower, Lesley J. Ashton, John A. Heath, Bruce K. Armstrong

Brief report

Prevalence of HPV types in cervical specimens from an integrated healthcare delivery system: baseline assessment to measure HPV vaccine impact

Eileen F. Dunne, Nicola P. Klein, Allison L. Naleway, Roger Baxter, Sheila Weinmann, Karen Riedlinger, Barbara Fetterman, Martin Steinau, Mariela Z. Scarbrough, Julianne Gee, Lauri E. Markowitz, Elizabeth R. Unger

Erhöhte Mortalität bei postpartalem Brustkrebs

07.05.2024 Mammakarzinom Nachrichten

Auch für Trägerinnen von BRCA-Varianten gilt: Erkranken sie fünf bis zehn Jahre nach der letzten Schwangerschaft an Brustkrebs, ist das Sterberisiko besonders hoch.

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

07.05.2024 Harnblasenkarzinom Nachrichten

Eine hypertherme intravesikale Chemotherapie mit Mitomycin kann für Patienten mit hochriskantem nicht muskelinvasivem Blasenkrebs eine Alternative zur radikalen Zystektomie darstellen. Kölner Urologen berichten über ihre Erfahrungen.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Bessere Prognose mit links- statt rechtsseitigem Kolon-Ca.

06.05.2024 Kolonkarzinom Nachrichten

Menschen mit linksseitigem Kolonkarzinom leben im Mittel zweieinhalb Jahre länger als solche mit rechtsseitigem Tumor. Auch aktuell ist das Sterberisiko bei linksseitigen Tumoren US-Daten zufolge etwa um 11% geringer als bei rechtsseitigen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.